Biogen agrees to pay $900 million in largest FCA Settlement Ever Secured without Government’s Intervention
FDA Law Blog
OCTOBER 3, 2022
As many of our readers know, the federal antikickback statute prohibits offering or paying healthcare professionals (HCPs) anything of value as an inducement or reward for ordering or prescribing an item or service reimbursable by federal health care programs. See 42 U.S.C. 1320a-7b(b).
Let's personalize your content